Spq Test System
Lipoprotein, Low-Density, Antigen, Antiserum, Control. 510(k) K982708, from DiaSorin, Inc. (Columbia, MD). Product code DFC, class 2.
As of Nov 20, 2026, K982708 is an FDA 510(k) held by DiaSorin, Inc., substantially equivalent on Apr 2, 1999 after 241 days, with 1 recall tied to it in FDA's recall database.
- Review time: 241 days
- Recalls: 1
- Cited as a predicate by: 1 device
- LP(A)-Latex Seiken Assay KitK013359 · Denka Seiken'S · Mar 8, 2002
| Started | Recall | Status |
|---|---|---|
| Jan 10, 2005 | Z-0636-05QC testing of the Antibody Reagent Set for Lp(a) SPQ Test System it was discovered that the background was failing high of the specification. Through substitution testing it was determined that the Lp(a) diluent, part… | Terminated |
- Lipoprotein (a) Molarity AssayK253069 · Diazyme Laboratories, Inc. · Jun 16, 2026
- Tina-quant Lipoprotein(a) Gen.2 MolarityK241220 · Roche Diagnostics Operations · Jan 24, 2025
- Lp(a) UltraK211058 · SENTINEL CH. SpA · Dec 22, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 4, 1998
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5600
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files